Company Filing History:

8 out of 10,754

Basf Aktiengesellschaft

Years Active: 1992-2007

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. RE39608 - Substituted benzimidazoles and their use as PARP inhibitors (2007-04-30),

2. 7087637 - Substituted indoles which are PARP inhibitors (2006-08-08),

3. 7041675 - Heterocyclic compounds and their use as PARP inhibitors (2006-05-09),

4. 6737421 - Cyclo-alkyl substituted benzimidazoles and their use as PARP inhibitors (2004-05-18),

5. 6696437 - Heterocyclically substituted benzimidazoles, the production and application thereof (2004-02-24),

6. 6686369 - &agr;-hydrdroxylic acid derivatives, their production and use (2004-02-03),

7. 6448271 - Substituted benzimidazoles and their use as parp inhibitors (2002-09-10),

8. 6103732 - Carboxylic acid derivatives, their production and use (2000-08-15),

9. 6004988 - Carboxylic acid derivatives, their preparation and their use (1999-12-21),

10. 5296485 - Substituted N-phenylpiperidines and drugs therefrom (1994-03-22),

11. 5260330 - Substituted anilides (1993-11-09),

12. 5260318 - Phenylpiperidylamines and drugs containing them (1993-11-09),

13. 5175174 - Phenylpiperidinylamines and drugs containing these (1992-12-29),

Title: The Innovative Journey of Sabine Schult

Introduction

Sabine Schult, a prominent inventor based in Speyer, Germany, has made significant contributions to the field of pharmaceutical chemistry. With an impressive portfolio of 13 patents, Schult is renowned for her innovative work focused on novel compounds with therapeutic applications. Her expertise lies in the development of poly(ADP-ribose) polymerase (PARP) inhibitors, which are essential in cancer treatment.

Latest Patents

Among her latest patents, Schult has developed substituted benzimidazoles and their use as PARP inhibitors. This groundbreaking work involves compounds of the formula Ia or Ib, showcasing her ability to design innovative therapeutic agents. Additionally, she has designed substituted indoles that serve as PARP inhibitors, contributing to the preparation of novel drugs targeting this critical enzyme involved in cellular processes.

Career Highlights

Throughout her career, Sabine Schult has held key positions in leading companies such as BASF Aktiengesellschaft and Abbott GmbH & Co. KG. Her work in these esteemed organizations has solidified her reputation as an expert in her field, driving innovation and paving the way for new drug development.

Collaborations

Schult has collaborated with notable professionals such as Wilfried Lubisch and Michael Kock. These partnerships have further enhanced her research initiatives and played a significant role in the success of her inventions and patents.

Conclusion

In summary, Sabine Schult is an inspiring inventor whose contributions to pharmaceutical innovations continue to impact the scientific community positively. With her extensive experience and a strong focus on developing effective therapies, she remains a key figure in advancing drug development and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.